Millennium Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-106,671
| Closed | -$3.61M | – | 6264 |
|
|
2025
Q4 | $3.61M | Buy |
106,671
+67,393
| +172% | +$2.09M | ﹤0.01% | 3373 |
|
|
2025
Q3 | $1.01M | Buy |
39,278
+16,854
| +75% | +$221K | ﹤0.01% | 4621 |
|
|
2025
Q2 | $179K | Buy |
22,424
+10,534
| +89% | +$80.3K | ﹤0.01% | 5396 |
|
|
2025
Q1 | $116K | Sell |
11,890
-80,323
| -87% | -$790K | ﹤0.01% | 5412 |
|
|
2024
Q4 | $1.17M | Sell |
92,213
-27,783
| -23% | -$353K | ﹤0.01% | 4074 |
|
|
2024
Q3 | $1.93M | Sell |
119,996
-8,012
| -6% | -$162K | ﹤0.01% | 3728 |
|
|
2024
Q2 | $3.12M | Buy |
128,008
+97,739
| +323% | +$4.51M | ﹤0.01% | 3146 |
|
|
2024
Q1 | $2.17M | Sell |
30,269
-25,325
| -46% | -$3.52M | ﹤0.01% | 3661 |
|
|
2023
Q4 | $11.1M | Sell |
55,594
-6,301
| -10% | -$780K | ﹤0.01% | 2082 |
|
|
2023
Q3 | $8.23M | Buy |
61,895
+47,171
| +320% | +$7.7M | ﹤0.01% | 2229 |
|
|
2023
Q2 | $2.2M | Buy |
14,724
+6,047
| +70% | +$942K | ﹤0.01% | 3396 |
|
|
2023
Q1 | $1.27M | Buy |
8,677
+1,851
| +27% | +$374K | ﹤0.01% | 3861 |
|
|
2022
Q4 | $1.08M | Sell |
6,826
-6,215
| -48% | -$995K | ﹤0.01% | 4088 |
|
|
2022
Q3 | $2.51M | Sell |
13,041
-9,545
| -42% | -$1.81M | ﹤0.01% | 3539 |
|
|
2022
Q2 | $3.3M | Buy |
22,586
+12,771
| +130% | +$1.7M | ﹤0.01% | 3208 |
|
|
2022
Q1 | $1.73M | Buy |
9,815
+6,115
| +165% | +$1.15M | ﹤0.01% | 4026 |
|
|
2021
Q4 | $1.09M | Sell |
3,700
-58,351
| -94% | -$15.6M | ﹤0.01% | 4335 |
|
|
2021
Q3 | $15.4M | Buy |
62,051
+19,304
| +45% | +$5.1M | 0.01% | 1572 |
|
|
2021
Q2 | $10.9M | Sell |
42,747
-9,847
| -19% | -$1.84M | 0.01% | 1798 |
|
|
2021
Q1 | $9.34M | Buy |
52,594
+9,261
| +21% | +$1.53M | 0.01% | 1860 |
|
|
2020
Q4 | $6.85M | Buy |
43,333
+20,215
| +87% | +$4.4M | ﹤0.01% | 2142 |
|
|
2020
Q3 | $5.96K | Buy |
23,118
+18,661
| +419% | +$4.14M | 0.01% | 1678 |
|
|
2020
Q2 | $1.03M | Sell |
4,457
-1,083
| -20% | -$167K | ﹤0.01% | 2971 |
|
|
2020
Q1 | $943K | Buy |
+5,540
| New | +$1.26M | ﹤0.01% | 2507 |
|
Millennium Management's RAPT Position: Q1 2026 in Review
Millennium Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 106,671 shares — an estimated $3.61M sold.
Millennium Management first reported a position in RAPT in Q1 2020 and held it in 24 quarters. The position peaked at $15.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Millennium Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 106,671 RAPT Therapeutics shares in Q1 2026, an estimated $3.61M.
- Millennium Management first reported a position in RAPT Therapeutics in Q1 2020 and held it in 24 quarters.
- Millennium Management's RAPT Therapeutics position peaked at $15.4M in Q3 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.